T2 Biosystems, Inc. (TTOO) vs XWELL, Inc. (XWEL)

T2 Biosystems, Inc. and XWELL, Inc. are both Diagnostics & Research companies. XWELL, Inc. is the larger, with a market value of $7.6M against $6.5M — 1.2× the size. XWELL, Inc. grew revenue faster over the last twelve months: −7.58% against −30.2%. XWELL, Inc. has the higher net margin (−117.8% vs −559.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, XWELL, Inc. leads on 9 and T2 Biosystems, Inc. on 5.

Valuation

Metric TTOO XWEL Diagnostics & Research median
P/E n/m n/m 33.95
P/S n/m 0.27 4.87
P/B n/m 0.92 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 0.64 0.30 5.66
Earnings yield 0.00% (597.75%) (1.75%)
Free cash flow yield 0.00% (178.41%) (0.13%)

Profitability

Metric TTOO XWEL Diagnostics & Research median
Gross margin (76.76%) 34.34% 50.89%
Operating margin (542.59%) (61.31%) (8.57%)
Net margin (559.52%) (117.83%) (6.37%)
Free cash flow margin (476.64%) (47.65%) 0.00%
Return on equity 277.61% (557.21%) (2.92%)
Return on assets (140.00%) (155.10%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TTOO XWEL Diagnostics & Research median
Revenue growth (TTM) (30.19%) (7.58%) 7.69%
EPS growth (last fiscal year) 98.44% (38.80%) —
Revenue growth, 5-year CAGR (7.29%) 28.35% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TTOO XWEL Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 0.40 2.27 2.02
Net debt to EBITDA 0.32 (0.08) 0.78

Dividend

Metric TTOO XWEL Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric TTOO XWEL Diagnostics & Research median
Market cap 6.48m 7.64m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack